Complement Regulation to Undo Systemic Harm in Preeclampsia

Clinical trial NCT04725812 · TERMINATED

Trial details

NCT number: NCT04725812
Sponsor: Cedars-Sinai Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Preeclampsia Severe Preeclampsia Eculizumab HELLP HELLP Syndrome HELLP Syndrome Second Trimester Pregnancy Related AHUS PNH Complement Regulatory Factor Defect Complement Abnormality HELLP Syndrome Third Trimester

Start date: 2021-09-13
Primary completion: 2021-12-07
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.